Beyond anti-GBM disease, the detection of GBM component antibodies such as perlecan and peroxidasin, in transplantation and AAV respectively, raises the possibility that basement membrane antibody panels could have utility across a spectrum of renal and pulmonary immune-mediated disorders. Here, PXDN is linked to glioblastoma.